Atria Wealth Solutions Inc. Decreases Stock Holdings in VanEck Pharmaceutical ETF (NASDAQ:PPH)

Atria Wealth Solutions Inc. cut its holdings in VanEck Pharmaceutical ETF (NASDAQ:PPH) by 74.1% during the fourth quarter, according to the company in its most recent 13F filing with the Securities & Exchange Commission. The fund owned 3,721 shares of the company’s stock after selling 10,667 shares during the period. Atria Wealth Solutions Inc. owned about 0.07% of VanEck Pharmaceutical ETF worth $303,000 at the end of the most recent reporting period.

Several other hedge funds have also recently made changes to their positions in PPH. Allworth Financial LP bought a new position in VanEck Pharmaceutical ETF during the fourth quarter valued at $28,000. Commonwealth Equity Services LLC raised its position in VanEck Pharmaceutical ETF by 2.3% in the 3rd quarter. Commonwealth Equity Services LLC now owns 18,951 shares of the company’s stock worth $1,513,000 after purchasing an additional 422 shares during the period. WT Wealth Management boosted its position in shares of VanEck Pharmaceutical ETF by 1.5% during the third quarter. WT Wealth Management now owns 35,458 shares of the company’s stock valued at $2,832,000 after buying an additional 530 shares during the period. Cary Street Partners Investment Advisory LLC bought a new position in shares of VanEck Pharmaceutical ETF during the third quarter valued at approximately $60,000. Finally, Raymond James & Associates raised its holdings in shares of VanEck Pharmaceutical ETF by 19.6% in the third quarter. Raymond James & Associates now owns 4,887 shares of the company’s stock worth $390,000 after buying an additional 800 shares during the period.

VanEck Pharmaceutical ETF Stock Up 0.2 %

PPH opened at $88.56 on Thursday. The business has a fifty day moving average of $88.32 and a 200 day moving average of $84.15. The stock has a market cap of $526.05 million, a P/E ratio of 21.04 and a beta of 0.47. VanEck Pharmaceutical ETF has a 52-week low of $74.05 and a 52-week high of $91.16.

VanEck Pharmaceutical ETF Announces Dividend

The business also recently announced a dividend, which was paid on Friday, April 5th. Shareholders of record on Tuesday, April 2nd were paid a $0.5328 dividend. The ex-dividend date of this dividend was Monday, April 1st.

VanEck Pharmaceutical ETF Profile

The VanEck Pharmaceutical ETF (PPH) is an exchange-traded fund that is based on the MVIS US Listed Pharmaceutical 25 index, a market-cap-weighted index of 25 of the largest global pharmaceutical firms. PPH was launched on Feb 1, 2000 and is managed by VanEck.